NRM, relapse incidence, and OS of patients according to their iNKT reconstitution in landmark analyses at day 90. (A) Cumulative incidence of NRM was significantly increased in patients with iNKT/T ratios < 10⁻³ (low iNKT/T group; P = .009, Gray test). (B) The cumulative incidence of relapse was similar between patients whether or not they reached iNKT/T ratios ≥ 10⁻³ (high vs low iNKT/T group; P = .770, Gray test). (C) OS was significantly prolonged for patients reaching iNKT/T ratio ≥ 10⁻³ (high iNKT/T group; P = .002, logrank test). NS indicates nonsignificant. Only 1 patient died before day 90 and was therefore not included in the landmark analysis.